Company Profile
Updated: 17-SEP-09Genaissance Pharmaceuticals Inc.
Private Company, Headquarters Location
5 Science Pk., New Haven, CT 06511-1966, United States
(203)773-1450, (203)562-9377 fax, http://www.genaissance.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Pharmacogenomic technology development.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Other News To Note.
BIOWORLD Today; 11/4/2009; 2233 words; ...necessary infrastructure. o Genaissance Pharmaceuticals Inc., of New Haven, Conn., and Prometheus Laboratories Inc., of San Diego, expanded...Prometheus licensed rights from Genaissance to a thiopurine S-methyltransferase...
Appointments And Advancements.
BIOWORLD Today; 11/4/2009; 1310 words; ...president. Epicyte Pharmaceutical Inc., of San Diego...development. Favrille Inc., of San Diego...operations. FeRx Inc., of San Diego...medical affairs. Genaissance Pharmaceuticals Inc., of New Haven...
Clinical Data Scooping Up Icoria For $12.5M In Stock.
BIOWORLD Today; 11/3/2009; 1029 words; ...biomarkers with molecular diagnostics, Icoria Inc. is being taken over by Clinical Data Inc. in an all-stock deal worth about...Clinical Data disclosed its plan to buy out Genaissance Pharmaceuticals Inc. (OTC BB:ICOR). Icoria's shares...
U.S. Patent Disclosures.
BIOWORLD Today; 11/3/2009; 674 words; Entelos Inc., of Foster City, Calif., was...measuring the intracellular calcium. Genaissance Pharmaceuticals Inc., of New Haven, Conn., received...said its subsidiary, Genetronics Inc., received U.S. Patent No. 6...
Genaissance, Diagnostics Firm Plan To Merge In $56M Deal.
BIOWORLD Today; 11/3/2009; 1016 words; ...pharmacogenomics, Clinical Data Inc. is taking over Genaissance Pharmaceuticals Inc. in an all-stock deal...Haven, Conn.-based Genaissance's stock (NASDAQ...pharmacogenomics services to pharmaceutical, biotech and agricultural...
Recent News Articles
- Clinical Data buys Genaissance in all-stock deal worth $56M.(Genaissance Pharmaceuticals Inc.)(Brief Article)
Pharma Marketletter - October 17, 2005 - Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2005 Conference Call.
PR Newswire - April 26, 2005 - Genaissance Pharmaceuticals, Inc. Invites You to Participate in its Fourth Quarter 2004 Conference Call.
PR Newswire - February 03, 2005 - Genaissance Pharmaceuticals, Inc. Invites You to Participate in Its Third Quarter 2004 Conference Call.
PR Newswire - November 08, 2004
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning